Indo Borax & Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 13, 2025.
INDOBORAX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.0 pts less than Nifty Microcap 250 and 3.4 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Indo Borax & Chemicals reported its audited standalone and consolidated results for Q4 and FY ended March 31, 2025. Revenue from operations declined about 8.4% YoY to Rs. 17,526 lakhs, while net profit grew around 9% to Rs. 4,188 lakhs, lifting EPS to Rs. 13.05 from Rs. 11.97. The Board recommended a dividend of Rs. 1 per share (100% of face value), subject to shareholder approval. The statutory auditor issued an unmodified opinion but included an Emphasis of Matter regarding an inter-corporate deposit given to a third party that is undergoing corporate insolvency resolution under the IBC code, with the outcome pending before NCLT. A major red flag is that net cash flow from operating activities turned sharply negative at Rs. (6,094) lakhs (standalone), versus a positive Rs. 6,971 lakhs in FY24, dragging cash and equivalents down to Rs. 3,851 lakhs from Rs. 11,059 lakhs.
Profit growth and dividend are positives for shareholders, but the decline in top-line revenue and the swing to deeply negative operating cash flow raise quality-of-earnings concerns. The unresolved inter-corporate deposit to a party under IBC insolvency is an additional risk worth monitoring, though the auditor's opinion remains unmodified.